1 Apr 2020
AmCad BioMed's devices are designed to enable early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis and obstructive sleep apnea. The softwares developed by AmCad BioMed enable rapid analysis of ultrasound scan images.
28 Feb 2020
IDTechEx interviewed AmCad BioMed, a Taiwan-based company that developed a robotic platform for the rapid detection of obstructive sleep apnoea (OSA). OSA is vastly undiagnosed, with reports saying up to 85% of people with the condition are not aware they have it.